Targeting and disabling a certain protein essential to transporting glucose properly through cells (Glucose Transporter 1, or ...

Icecure Medical ( ($ICCM) ) just unveiled an update. On December 10, 2025, IceCure Medical announced that its ProSense® Cryoablation technology ...

Abstracts presented include 3 studies involving 263 patients, adding to a growing body of evidence across diverse patient populations supporting broader adoption of ProSense (R) ...

A session at the AHA Scientific Sessions 2025 focused on dilemmas related to antithrombotic therapy following catheter ablation in patients with AF.

Abstracts presented include 3 studies involving 263 patients, adding to a growing body of evidence across diverse patient populations supporting broader ...

Some of our most promising biotechs have taken part in a pre yuletide rush of clinical trial updates – and there is much to ...

ProSense® systems are being sold and installed at new locations across North America, including some of the most highly ...

DaVita, a leading provider of kidney care services, today announced two key additions to its executive leadership team: Stephanie Hendrickson has been named Chief People Officer (CPO) and Steve ...

We’ve known about holiday heart (or holiday heart syndrome) for almost 50 years. Back in the 1970s, it was described as an abnormal heart rhythm (or arrythmia) in healthy people without heart disease ...

Complete response (CR) observed in 70% (35/50) of patients with low-grade upper tract urothelial cancer (UTUC) who completed ...

Cryogenic flow control enhances the efficacy and precision of cryoablation proceduresRobust IP portfolio becomes increasingly ...